SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as a diagnostic marker, a key ...

Next-generation sequencing (NGS) is an important component of first-line treatment selection for metastatic non–small-cell lung cancer (NSCLC) and is typically ordered by medical oncologists in the ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed ...

A new study combines cfDNA fragmentomes and protein biomarkers to vastly improve early detection of ovarian cancer, offering a cost-effective and robust tool for mass screening. Study: Early detection ...

Clinical information of the collected samples. (A) The age distribution of the normal group and GDM group. (B) The weight distribution of the normal group and GDM group. (C) The sample time ...

The discovery that blood carries short fragments of DNA, known as cell-free DNA (cfDNA), has opened a new window into biological processes and, in combination with advances in sequencing, is ...

Cell-free DNA (cfDNA) library preparation is fundamental for successful and efficient next-generation sequencing (NGS) workflows. Researchers apply these techniques to a wide range of platforms, ...